"Bone Diseases, Metabolic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Diseases that affect the METABOLIC PROCESSES of BONE TISSUE.
| Descriptor ID |
D001851
|
| MeSH Number(s) |
C05.116.198 C18.452.104
|
| Concept/Terms |
Bone Diseases, Metabolic- Bone Diseases, Metabolic
- Metabolic Bone Diseases
- Bone Disease, Metabolic
- Disease, Metabolic Bone
- Diseases, Metabolic Bone
- Metabolic Bone Disease
|
Below are MeSH descriptors whose meaning is more general than "Bone Diseases, Metabolic".
Below are MeSH descriptors whose meaning is more specific than "Bone Diseases, Metabolic".
This graph shows the total number of publications written about "Bone Diseases, Metabolic" by people in this website by year, and whether "Bone Diseases, Metabolic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2003 | 1 | 0 | 1 |
| 2005 | 0 | 2 | 2 |
| 2006 | 3 | 1 | 4 |
| 2007 | 1 | 2 | 3 |
| 2008 | 1 | 0 | 1 |
| 2009 | 1 | 0 | 1 |
| 2011 | 2 | 0 | 2 |
| 2013 | 0 | 1 | 1 |
| 2014 | 3 | 1 | 4 |
| 2015 | 2 | 0 | 2 |
| 2016 | 0 | 1 | 1 |
| 2017 | 1 | 1 | 2 |
| 2018 | 2 | 0 | 2 |
| 2019 | 0 | 2 | 2 |
| 2020 | 2 | 1 | 3 |
| 2021 | 0 | 1 | 1 |
| 2022 | 0 | 1 | 1 |
| 2023 | 2 | 0 | 2 |
| 2024 | 1 | 0 | 1 |
| 2026 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Bone Diseases, Metabolic" by people in Profiles.
-
Prevalence of bone mineral disease in children with acute kidney disease on continuous kidney replacement therapy: a case-control study. Pediatr Nephrol. 2026 Jul; 41(7):2079-2087.
-
Vitamin D and metabolic bone disease in prolonged continuous kidney replacement therapy: a prospective observational study. BMC Nephrol. 2024 Aug 19; 25(1):265.
-
Sarcopenia is associated with osteopenia and impaired quality of life in children with genetic intrahepatic cholestatic liver disease. Hepatol Commun. 2023 11 01; 7(11).
-
Craniosynostosis in primary metabolic bone disorders: a single-institution experience. Childs Nerv Syst. 2023 12; 39(12):3583-3588.
-
Early identification of a 12-bp tandem duplication in TNFRSF11A encoding receptor activator of nuclear factor-kappa B (RANK): Clinical characterization and response to bisphosphonate therapy. Bone. 2023 05; 170:116698.
-
El-Hattab-Alkuraya syndrome caused by biallelic WDR45B pathogenic variants: Further delineation of the phenotype and genotype. Clin Genet. 2022 05; 101(5-6):530-540.
-
Bone mineral density surveillance for childhood, adolescent, and young adult cancer survivors: evidence-based recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Lancet Diabetes Endocrinol. 2021 09; 9(9):622-637.
-
Gastrointestinal Hemorrhage: A Manifestation of the Telomere Biology Disorders. J Pediatr. 2021 03; 230:55-61.e4.
-
Effect on metabolic bone disease markers in the neonatal intensive care unit with implementation of a practice guideline. J Perinatol. 2020 08; 40(8):1267-1272.
-
Secondary Fracture Prevention: Consensus Clinical Recommendations from a Multistakeholder Coalition. J Orthop Trauma. 2020 Apr; 34(4):e125-e141.